As a market pioneer, our focus is on the international distribution of the innovative IMPACT-Platform for Autologous Cell Therapies.
IMPACT International GmbH was founded in 2018 to facilitate the international sales of IMPACT Platform for Autologous Cell Therapies and to serve distribution partners across the world.
IMPACT Platform for Autologous Cell Therapies is the revolutionary new centrifuge for the preparation of many different autologous blood preparations. The Platform is manufactured in Germany and CE marked by Plasmaconcept AG, Cologne.
IMPACT International GmbH
Breite Str. 2-4
Phone: +49 (0)221 84 56 25-0
Fax: +49 (0)221 84 56 25-25